Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, working in conjunction with the Dutch technology company ECCT (Experts in Communications & Connectivity Technology), has developed a smart blister pack for a global pharmaceutical corporation to enhance medication adherence by clinical trial participants. The introduction of this innovative electronic tool for managing and tracking processes during clinical trials marks a milestone for this global group of companies.
While clinical trials require high accuracy, reliable workflow, efficiency, speed and flexibility, the conventional, non-automated processes are frequently error-prone. Medication adherence by participating patients is critical for the successful outcome of clinical trials, but often difficult to track. Usually, about 20 percent of patients do not adhere to medication therapy, forcing trial organizers to compensate for the resulting accuracy deficit by increasing patient populations up to 60 percent.
To improve medication adherence, Schreiner MediPharm joined forces with ECCT and the pharmaceutical corporation involved to develop a smart packaging solution for patient compliance monitoring. The solution works as follows: When a patient pushes a tablet from the blister pack, data is generated in real time. This data may include medication type, extraction time and specific cavity, and is automatically stored in the smart packaging and transmitted to a database via smartphone app or reader.
This digital therapy monitoring allows physicians, for example, to verify that patients have taken their medicine at the right time. Additionally, the technology makes interactive communication between physicians and patients possible. For instance, physicians can send compliance reminders or dose adjustments to patients.
The smart packaging solution includes printed electronics without impacting the packaging design, and a smart database platform enables diverse data transfers and analyses. Schreiner MediPharm supplied the required expertise in innovative printing technology, and ECCT provided the package’s smart sensors.
The benefits of utilizing this innovative digital patient compliance monitoring tool include:
- Increased efficiency of the clinical trial process as a result of reduced manual documentation and monitoring
- Enhanced data quality and reduced delinquency rate due to non-compliance
- Greater flexibility in adjusting complex therapies and trial workflows
- Shortening of trial periods and accelerated approval process for new medicines
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, has developed a new label-cap combination that protects the integrity of original medicine containers, helping to prevent illegal reuse through clear, irreversible first-opening indication.
Schreiner MediPharm and Applied DNA Sciences offer forensic counterfeit-proof feature for pharma labels
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions, now offers a new forensic authentication feature for pharmaceutical labels in cooperation with Applied DNA Sciences. SigNature DNA is a high-security feature based on DNA markers with which pharmaceutical manufacturers can protect products against counterfeiting, and patients against potential health risks.
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions, has collaborated with B. Braun Medical Inc., located in Bethlehem, PA, who recently launched its prefilled syringe of Heparin Sodium Injection, USP utilizing Schreiner MediPharm’s label- integrated Needle-Trap system to the U.S. market.
Combined expertise: Schreiner MediPharm and Edelmann Group develop demo version of a smart packaging solution
Schreiner MediPharm has combined its expertise in innovative specialty labels and integrated solutions with folding box manufacturer Edelmann. The result is a smart medicine packaging solution with diverse digital features.
A novel dosing syringe label by Schreiner MediPharm supports reliable and exact dosing of a medicine for children as part of a clinical trial. The specialty label was developed for the syringe system made by Raumedic. It serves as a visual barrier, protecting the adjustment button and prevents healthcare staff from accidently activating the mechanism too early.
Schreiner MediPharm introduces BitSecure Mobile, a digital counterfeiting detection solution
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, has introduced BitSecure Mobile, a digital counterfeiting detection solution to help fight illegal trade in counterfeit medicines.
Schreiner MediPharm develops multifunctional covert-hologram seal for tamper protection
Schreiner MediPharm has developed a multifunctional Covert-Hologram Seal that offers reliable first-opening indication and tamper evidence, plus counterfeiting protection. The seal, which features an irreversible, holographic effect, complies with the Falsified Medicines Directive 2011/62/EU that will be enforced from February 2019.
Schreiner MediPharm develops smart blister pack for clinical trial
Schreiner MediPharm has developed a smart blister pack for digital patient compliance monitoring to enhance medication adherence by clinical trial participants. Schreiner MediPharm implemented the smart packaging solution together with the Dutch technology company ECCT (Experts in Communications and Connectivity Technology). Employment of this electronic tool to manage and track processes during clinical trials marks a milestone for the pharmaceutical manufacturer.
Schreiner MediPharm supports Biotest AG with “Late Stage Customization” service for supply chain agility
Flexible production of functional labels successfully addresses market segmentation. Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, recently implemented a special Late Stage Customization service in partnership with its customer, Biotest AG. The new process allows for faster production of functional labels on short demand. As a result, Biotest benefits from greater flexibility and is able to respond to market requirements with requisite agility, while Schreiner MediPharm assists its customer in meeting the demands of current segmentation trends in the pharmaceutical industry.
Schreiner MediPharm develops multi-functional labels for SHL Medical Auto Injectors
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 60 years, has developed specialty labels for demo devices of various SHL Medical auto injector models in which safety and patient ease of use are paramount. .
Schreiner Medipharm develops innovative label with self-lifting starter tab for small vials
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 60 years, has introduced a new version of its Pharma-Comb SL (Self-Lifting) label with a special starter tab.
Pharma-Tac Plus Label from Schreiner MediPharm wins first place in North American Tag and Label Manufacturers Institute International Competition
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 60 years, has been recognized with a first place award for its Pharma-Tac Plus hanging label.
- Elias Bittan
- Product Info
- Created 06 Jun 2018
- Modified 19 Jun 2018
- Hits 686